GLP-1 Market
LLY $1157.08 ▼ -2.3% NVO $37.91 ▼ -1.0% PFE $28.52 ▼ -0.7% VKTX $32.60 ▲ +2.5% KLRA $11.42 ▲ +3.9% GPCR $31.27 ▼ -4.3% RHHBY $51.91 ▼ -0.7%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

HRS-1301

HRS-1301

Company
Shandong Suncadia Medicine Co., Ltd.
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 1, 2026

Find a Clinical Trial Near Me

See recruiting studies for HRS-1301 and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07229937

    A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 189 participants Est. completion 2026-08 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT06857253

    A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subjects

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 84 participants Est. completion 2025-08-12 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT07097831

    A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 16 participants Est. completion 2025-11-07 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT07322016

    A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 36 participants Est. completion 2026-08-04 1 site Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT07608705

    A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 16 participants Est. completion 2026-08-24 1 site Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: HRS-1301, HRS-1301 Tablets

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.